This site is intended for Healthcare Professionals only.

Zentiva launches Buspirone 15mg and 30mg strength tablets


Share post:

Zentiva, one of the leading developers and suppliers of prescription medicines and consumer brands has launched 15 mg and 30 mg Buspirone tablets.

This medication is indicated for the treatment of short-term management of anxiety disorders and the relief of symptoms of anxiety with or without accompanying symptoms of depression.

Luke Hart, General Manager commented, “Zentiva is excited to announce this new addition to our Value Added Medicines portfolio, continuing to meet the unfulfilled needs of patients.”

He continues, “the launch of our 15mg and 30mg Buspirone Tablets will enable more flexible and accurate dosing – allowing for simple and convenient dosing regimens for patients with anxiety disorders.”


Please enter your comment!
Please enter your name here

Current Issue March 2024

Related articles

Common antibiotic for whooping cough treatment ‘completely out of stock’ – Dr. Leyla Hannbeck

Whooping cough caused five infant deaths in the first quarter of 2024, according to UKHSA Pharmacists in the UK...

Labour with Nuffield Health to aid thousands of NHS staff with joint pain return to work

Nurses accounted for 52,000 of sick days, doctors for 3,500, both up since 2019 as per the Labour...

UWE Bristol and Bedminster Pharmacy to pioneer antimicrobial stewardship

The collaboration between UWE Bristol and Bedminster Pharmacy to address societal challenges In a collaborative effort to combat the...

What is the Importance of Proper Dental Care for the Entire Family?

Dental care is often seen as a routine part of our healthcare regimen, but its significance cannot be...